Takeda Pharmaceutical Company Limited (TAK) Reports FY EPS of JPY484.00
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts TAK Hot Sheet
Join SI Premium – FREE
Takeda Pharmaceutical Company Limited (NYSE: TAK) reported FY2023 EPS of JPY484.00. Revenue for the year came in at JPY4263.8 billion.
GUIDANCE:
Takeda Pharmaceutical Company Limited sees FY2024 EPS of JPY431.00. Takeda Pharmaceutical Company Limited sees FY2024 revenue of JPY4350 billion.
For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- Customers Bancorp (CUBI) Tops Q3 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
